Global Fetal Bovine Serum Market | Opportunity Analysis & Industry Forecast to 2025 - ResearchAndMarkets.com

The "Fetal Bovine Serum Market by Application and End User: Global Opportunity Analysis and Industry Forecast, 2018-2025" report has been added to ResearchAndMarkets.com's offering.

According to this report, the global fetal bovine serum market was valued at $695 million in 2017, and is projected to reach $ 1,037 million by 2025, growing at a CAGR of 5.1 % from 2018 to 2025. North America was the highest revenue contributor in 2017 and is anticipated to maintain the same trend throughout the forecast period.

The growth of fetal bovine serum market size is primarily driven by the growing demand for biopharmaceuticals, rising biotech R&D activities in developing economies and increase in the support from government for research activities across the globe.

However, significant increase in its price within recent years is anticipated to hamper the fetal bovine serum market growth. Conversely, untapped potential of emerging markets are anticipated to provide lucrative opportunities in the near future to the key players operating in the fetal bovine serum market.

Based on fetal bovine serum market trends by application, the cell culture segment accounted for the majority share of the global market in 2017. This is attributed to the fact that fetal bovine serum finds its application in performing various animal cell cultures. It is most widely used supplement for cell cultures.

Depending on end user, the biotechnology & pharmaceutical company segment generated the maximum revenue of in 2017, and is anticipated to exhibit prominent growth, due to significant rise in R&D for the development of drugs, human & animal vaccines and others.

North America was the leading revenue contributor to the global market in 2018, owing to increase in healthcare investments by manufacturers and surge in R&D expenditure for various biotechnology research purposes. In addition, U.S. is the largest exporter of fetal bovine serum across the globe. Asia-Pacific is expected to witness the highest growth rate throughout the forecast period, due to increase in biotechnology R&D regarding development of biopharmaceuticals & vaccines and increase in the penetration of key market players in this region. Moreover, rise in government initiatives towards improving biotechnology research sector further boosts the market growth in this region.

The report provides an extensive competitive analysis and profiles of the key market players, such as GE Healthcare, Merck KGaA (Sigma Aldrich), HiMedia Laboratories Pvt., Ltd, Bio-Techne, Biowest, Biological Industries, Atlas Biologicals, Rocky Mountain Biologicals, PAN-Biotech, and Thermo Fisher Scientific Inc. The other players in the value chain (not included in the report) include Takara Bio, Inc., Cyagen Biosciences, PeproTech, Inc., Avantor Performance Materials, Caisson Laboratories, Inc., Cell Culture Technologies LLC, and Biomol GmbH.

Key Findings of the Market

• Based on end user, research laboratories accounted for nearly one-fifth share of the fetal bovine serum industry in 2017.
• The biopharmaceuticals application segment is anticipated to grow with the highest CAGR throughout the forecast period.
• Region wise, North America accounted for nearly two-fifths of the global fetal bovine serum market share in 2017.
• Asia-Pacific is anticipated to grow at the highest rate during the analysis period, followed by LAMEA.

Key Topics Covered

Chapter 1: Introduction

1.1. Report Description

1.2. Key Benefits for Stakeholders

1.3. Key Market Segments

1.4. Research Methodology

Chapter 2: Executive Summary

2.1. Key Findings of the Study

2.2. Key Findings

2.3. Cxo Perspective

Chapter 3: Market Overview

3.1. Market Definition and Scope

3.2. Parent/Peer Market Overview

3.3. Key Forces Shaping Fetal Bovine Serum Industry/Market

3.4. Pricing Analysis

3.5. Market Evolution/ Industry Roadmap

3.6. Value Chain Analysis

3.7. Impact of Government Regulations on Global Fetal Bovine Serum Market

3.8. Industry Pain Point Analysis

3.9. Case Studies

3.10. Market Dynamics

3.10.1. Drivers

3.10.1.1. Rise in R&D Investment

3.10.1.2. High Demand of Fetal Bovine Sera

3.10.1.3. Surge in Biopharmaceutical Production

3.10.2. Restraints

3.10.2.1. High Price

3.10.2.2. Increased Use of Alternatives

3.10.3. Opportunities

3.10.3.1. Untapped Potential of the Emerging Economies

Chapter 4: Fetal Bovine Serum Market, by Application

4.1. Overview

4.2. Biopharmaceuticals

4.3. Cell Culture

4.4. Human and Animal Vaccine Production

4.5. Others

Chapter 5: Fetal Bovine Serum Market, by End-user

5.1. Overview

5.2. Biotechnology & Pharmaceutical Company

5.3. Academic Institute

5.4. Research Laboratory

Chapter 6: Fetal Bovine Serum Market, by Region

6.1. Overview

6.2. North America

6.3. Europe

6.4. Asia-Pacific

6.5. LAMEA

Chapter 7: Competitive Landscape

7.1. Introduction

7.2. Market Share Analysis of Top Players, 2018 (%)

7.3. Top Winning Strategies

7.4. Competitive Dashboard

7.5. Competitive Heatmap

Chapter 8: Company Profiles: Fetal Bovine Serum Market

8.1. Bio-Techne (Atlanta Biologics)

8.2. Sera Scandia A/S (Biowest

8.3. Pan-Biotech

8.4. GE Healthcare (A Healthcare Division of GE Company)

8.5. Himedia Laboratories Pvt. Ltd.

8.6. Biological Industries

8.7. Atlas Biologicals

8.8. Merck KGaA (Sigma Aldrich)

8.9. Rocky Mountain Biologicals (RMBio)

8.10. Thermo Fisher Scientific Inc.

8.11. Other Key Player Profiles

Chapter 9: Appendix

For more information about this report visit https://www.researchandmarkets.com/r/smxw1